These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Preliminary results with a new non-steroidal antirheumatic drug (author's transl)].
    Author: Frank O, Klicpera M, Kolarz G, Scherak O.
    Journal: Wien Klin Wochenschr; 1975 Jun 27; 87(13):427. PubMed ID: 779281.
    Abstract:
    Thirty patients with classical or definite rheumatoid arthritis were treated over a 4-week period with diftalone, a new non-steroidal antirheumatic drug. The daily dosage ranged from 500 to 1000 mg. A good objective response was achieved in 69% of the patients. Diftalone was well tolerated. Side effects were noted in 11.8% of patients on 500 mg diftalone daily and in 18.8% of cases treated with the highest dosage (1000 mg daily). The optimum daily dosage appears to be 750 mg.
    [Abstract] [Full Text] [Related] [New Search]